APA (7th ed.) Citation

Mata, D. G. d. M. M., Pezo, R. C., Chan, K. K. W., Menjak, I., Eisen, A., & Trudeau, M. A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Mata, Danilo Giffoni de Mello Morais, Rossanna C. Pezo, Kelvin K. W. Chan, Ines Menjak, Andrea Eisen, and Maureen Trudeau. A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer. MDPI AG.

MLA (9th ed.) Citation

Mata, Danilo Giffoni de Mello Morais, et al. A Real-World Comparison Between Adjuvant Docetaxel with Cyclophosphamide (TC) and Anthracycline–Taxane Chemotherapy in Early HER-2 Negative Breast Cancer. MDPI AG.